-
Jichuan pharmaceutical pulifloxacin dispersible tablets will be on the market
Time of Update: 2020-04-03
In February 2014, two new varieties of pulifloxacin dispersible tablets and iron albuminosuccinate oral solution in Jichuan pharmaceutical industry were approved successively, and the marketing progre
-
Nanjing jianyouda heparin sodium injection and low molecular weight heparin calcium injection were inspected on site this month
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on June 17, the daparin sodium injection and low molecular weight heparin calcium injection declared by Nanjing Jianyou for pr
-
Baiyunshan 3.1 new drug gefitinib API accepted
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on August 4, the class 3.1 new drug gefitinib API declared by Baiyunshan was accepted At present, only the original research d
-
Huashen group's second application for production of 6.1 rhinitis traditional Chinese medicine Wulong granules was accepted
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on May 9, Wulong granules, a 6.1 rhinitis traditional Chinese medicine, which was applied for production (reexamination) by Hu
-
China's new drugs go to the United States!
Time of Update: 2020-04-03
The significance of the release of risperidone microsphere injection (ly03004) is that it is expected to become the first Chinese new drug approved and listed in the United States, and will represent
-
Application for clinical application of two new drugs of class 1.1 in Kelun pharmaceutical
Time of Update: 2020-04-03
According to the information from the State Food and Drug Administration on April 15, the application of ceftoren sodium phosphate for injection and ceftoren sodium for injection by Kelun Pharmaceutic
-
Changshan pharmaceutical is expected to obtain the production approval this month
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on May 6, the declaration and production status of the first heavy generic drug of Changshan Pharmaceutical Co., Ltd for hepar
-
New anticancer drugs of Fosun Pharmaceutical holding subsidiary obtained clinical approval again
Time of Update: 2020-04-03
Fosun Pharmaceutical announced today that the recombinant anti HER2 humanized monoclonal antibody for injection developed by its holding subsidiary Shanghai Fuhong Hanlin Biotechnology Co., Ltd (accep
-
Delivery information of semidone tablet, a new drug of Xianju pharmaceutical
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on June 4, the delivery information of semidone, a heavy-duty anti pregnancy drug, which was applied for production by Xianju
-
Three new drugs made in Beijing
Time of Update: 2020-04-03
After the Spring Festival, "pirfenidone", a new drug for the treatment of idiopathic pulmonary fibrosis, went on the market The production acceptance of the vaccine for the prevention of HFMD was comp
-
Thermodox, a liver cancer drug of celsion, a partner of Haizheng pharmaceutical, has not reached the end of clinical study
Time of Update: 2020-04-03
Haizheng Pharmaceutical Co., Ltd announced on the evening of January 31 that it would terminate its cooperation with the company on the product, because the company's partner, U.S celsion company, ann
-
Kangyuan pharmaceutical won the national science and technology progress award again
Time of Update: 2020-04-03
On January 8, good news came from the 2015 National Science and technology award conference: Kangyuan Pharmaceutical Co., Ltd led to complete the project of "establishment and application of quality s
-
CM118, a new anti lung cancer drug of Shanghai Zaixin medicine, has completed preclinical study
Time of Update: 2020-04-03
According to Dr Yu Ke, vice general manager of Zaixin medicine, Professor of Fudan University School of medicine and famous new drug R & D expert of "national thousand talents plan", CM118 project is
-
Zhifei biological heavyweight AC Hib vaccine is on the market after GMP certification
Time of Update: 2020-04-03
According to the information on CFDA website, the production workshops of two vaccine products, AC group meningococcal (combined) Haemophilus influenzae (combined) combined vaccine (hereinafter referr
-
3.1 the first batch of imitations of levetiracetam are coming out
Time of Update: 2020-04-03
According to the information on May 14 on the website of the State Food and Drug Administration (CFDA), zuoxiracetam APIs and tablets, a class 3.1 chemical drug, which are applied for production by xi
-
Application for clinical approval of Tianjin International Biomedical Joint Research Institute and Furen Pharmaceutical Co., Ltd. "special project for anti cancer of p-tetrabenzoamide"
Time of Update: 2020-04-03
The research and development project of "anti-cancer project of p-tetrabenzamide" jointly carried out by Tianjin International Biomedical Joint Research Institute and Furen Pharmaceutical Co., Ltd has
-
Temozolomide, a class 3.3 new antitumor drug of Hengrui medicine, has obtained clinical approval
Time of Update: 2020-04-03
Temozolomide for injection of Hengrui medicine has completed the clinical examination and approval, and is in the state of pending certification It is worth noting that the temozolomide for injection
-
Lansoprazole for injection in Wuzhong, Jiangsu Province will add a new army of drugs for digestive tract
Time of Update: 2020-04-03
According to the information released by the State Food and Drug Administration (CFDA), Lansoprazole for injection, a new class 3 chemical drug in Wuzhong, Jiangsu Province (600200 SH), will undergo o
-
The new biological antitumor drug of Haiwang, tegio, is about to obtain the production approval
Time of Update: 2020-04-03
The new anti-tumor drug of Haiwang biological heavyweight, tegio, will be approved for production soon, and it is expected to be listed in 2014 to improve the company's anti-tumor production line Acco
-
Changchun high tech live attenuated herpes zoster vaccine is expected to obtain clinical approval this year
Time of Update: 2020-04-03
Yang Zhanmin, chairman of Changchun hi tech, said at the 2013 performance presentation meeting that the new drug "live attenuated herpes zoster vaccine" that the company is applying for clinical appli
